Next Article in Journal
Interleukin-17A Gene Expression in Morbidly Obese Women
Next Article in Special Issue
SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals
Previous Article in Journal
Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia
Previous Article in Special Issue
Association between the NF-E2 Related Factor 2 Gene Polymorphism and Oxidative Stress, Anti-Oxidative Status, and Newly-Diagnosed Type 2 Diabetes Mellitus in a Chinese Population
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2015, 16(8), 17456-17468;

A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy

Institute of Clinical Pharmacology and Toxicology, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany
Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
Cardiological Outpatient Clinic Am Park Sanssouci, 14469 Potsdam, Germany
Klinik am See, Rehabilitation Center for Cardiovascular Diseases, 15562 Rüdersdorf, Germany
Center of Rehabilitation Research, University of Potsdam, 14469 Potsdam, Germany
Author to whom correspondence should be addressed.
Academic Editor: Emil Alexov
Received: 29 June 2015 / Revised: 16 July 2015 / Accepted: 23 July 2015 / Published: 30 July 2015
(This article belongs to the Collection Human Single Nucleotide Polymorphisms and Disease Diagnostics)
Full-Text   |   PDF [683 KB, uploaded 30 July 2015]


Cytochrome P450 17A1 (CYP17A1) catalyses the formation and metabolism of steroid hormones. They are involved in blood pressure (BP) regulation and in the pathogenesis of left ventricular hypertrophy. Therefore, altered function of CYP17A1 due to genetic variants may influence BP and left ventricular mass. Notably, genome wide association studies supported the role of this enzyme in BP control. Against this background, we investigated associations between single nucleotide polymorphisms (SNPs) in or nearby the CYP17A1 gene with BP and left ventricular mass in patients with arterial hypertension and associated cardiovascular organ damage treated according to guidelines. Patients (n = 1007, mean age 58.0 ± 9.8 years, 83% men) with arterial hypertension and cardiac left ventricular ejection fraction (LVEF) ≥40% were enrolled in the study. Cardiac parameters of left ventricular mass, geometry and function were determined by echocardiography. The cohort comprised patients with coronary heart disease (n = 823; 81.7%) and myocardial infarction (n = 545; 54.1%) with a mean LVEF of 59.9% ± 9.3%. The mean left ventricular mass index (LVMI) was 52.1 ± 21.2 g/m2.7 and 485 (48.2%) patients had left ventricular hypertrophy. There was no significant association of any investigated SNP (rs619824, rs743572, rs1004467, rs11191548, rs17115100) with mean 24 h systolic or diastolic BP. However, carriers of the rs11191548 C allele demonstrated a 7% increase in LVMI (95% CI: 1%–12%, p = 0.017) compared to non-carriers. The CYP17A1 polymorphism rs11191548 demonstrated a significant association with LVMI in patients with arterial hypertension and preserved LVEF. Thus, CYP17A1 may contribute to cardiac hypertrophy in this clinical condition. View Full-Text
Keywords: clinical study; genetics; heart; hypertension; cytochrome P450 17A1 (Cyp17A1) clinical study; genetics; heart; hypertension; cytochrome P450 17A1 (Cyp17A1)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Huber, M.; Lezius, S.; Reibis, R.; Treszl, A.; Kujawinska, D.; Jakob, S.; Wegscheider, K.; Völler, H.; Kreutz, R. A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy. Int. J. Mol. Sci. 2015, 16, 17456-17468.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top